COMMUNIQUÉS West-GlobeNewswire

-
Transactions in relation to share buyback program
11/09/2018 -
Amedisys Wins 15 Aster Awards for Home Health and Hospice Marketing
11/09/2018 -
Idera Pharmaceuticals Announces Corporate Organizational Changes
11/09/2018 -
Revive Therapeutics Introduces RELICANN™ a New Brand for Hemp-based CBD Wellness and Medical Cannabis Market
11/09/2018 -
IRADIMED CORPORATION Announces Clearance of MRI Compatible Patient Vital Signs Monitor in Japan
11/09/2018 -
Amicus Therapeutics Announces Board Appointments
11/09/2018 -
Abattis Strengthens Management Team and Provides Company Updates
11/09/2018 -
Auxly and Lotus Ventures Announce Investment and Signing of Definitive Long Term Purchase and Sale Agreement
11/09/2018 -
Nu-Med Plus, Inc. Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study
11/09/2018 -
Easton Pharmaceuticals Announces It Has Entered Into High Level Negotiations To Take Over a Profitable Hotel and a $17,000,000 Real Estate Asset Located In The Heart of Toronto, Ontario, Canada
11/09/2018 -
ChromaDex to Participate in “Conquering Aging” Briefing with Frost & Sullivan
11/09/2018 -
iKang Schedules 2018 Unaudited First Quarter Earnings Release on September 27, 2018
11/09/2018 -
Allscripts appointed to Health Systems Support Framework
11/09/2018 -
Solon Eiendom ASA – Primary insider notification
11/09/2018 -
Shire plc: Rule 2.9 Announcement
11/09/2018 -
NEOVACS ANNOUNCES THAT ITS PARTNER BIOSENSE GLOBAL HAS EXERCISED ITS OPTION TO ACQUIRE THE EXCLUSIVE LICENCE FOR IFNalpha KINOID TO TREAT LUPUS IN CHINA
11/09/2018 -
NÉOVACS ANNONCE LA LEVÉE DE L'OPTION DE LICENCE SIGNÉE AVEC BIOSENSE GLOBAL POUR LE DÉVELOPPEMENT EN CHINE DE L'IFNalpha KINOIDE DANS LE LUPUS
11/09/2018 -
Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis
11/09/2018 -
Biocartis Group NV: Biocartis Creates New Warrant Plan
11/09/2018
Pages